Ebola virus disease: societal challenges and new treatments
A. Mirazimi
págs. 227-237
Alcohol and cardiovascular diseases: where do we stand today?
Andrew Klansky
págs. 238-250
Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease
M. Belting, H.C. Christianson
págs. 251-263
Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases
A. Ambati, T. Poiret, B.M. Svahn, Davide Valentini, M. Khademi
págs. 264-276
Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment
D. Ferreira, Lucia Cavallini, E.M. Larsson, J.S. Muehlboeck
págs. 277-290
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
A.C. Shore, Helen Colhoun, A. Natali, C. Palombo, G. Östling
págs. 291-302
Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies
M. Böhm, H. Schumacher, D. Linz, J.C. Reil, C. Ukena
págs. 303-312
A genetic variant in the promoter of phosphate-activated glutaminase is associated with hepatic encephalopathy
L.B. Mayer, M. Krawczyk, F. Grünhage, F. Lammert, C.S. Stokes
págs. 313-322
Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease
S. Brauner, W. Zhou, C. Backlin, T.M. Green
págs. 323-332
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: